Latest Parathyroid gland Stories
During thyroidectomy (surgery to remove the thyroid gland), the technique surgeons use to identify an important nerve appears to make a difference in terms of complications such as impairment of the parathyroid glands (which make a hormone that controls calcium levels).
ZURICH, July 19, 2011 /PRNewswire/ -- Kuros Biosurgery AG, a biotechnology company focused on the development of novel biomaterials and bioactive-biomaterial combination products for trauma, wound and spinal indications, announced today that it has received Notice of Allowance for U.S.
RARITAN, N.J., Nov. 1, 2010 /PRNewswire/ -- Ortho Clinical Diagnostics today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the VITROSÂ® intact Parathyroid Hormone (iPTH) Assay.
Research shows that molecular imaging fusion with high resolution CT anatomy may result in more precise localization of parathyroid lesions.
COLLEGE STATION, Texas, Jan. 14 /PRNewswire/ -- Ronald B. Kuppersmith, MD, FACS, of The Texas Institute for Thyroid and Parathyroid Surgery, recently successfully performed his 20th robotic thyroid surgery at the College Station Medical Center in College Station, Texas.
Tulane University School of Medicine surgeon Dr. Emad Kandil is one of the first in the country to perform a new form of endoscopic surgery that uses a small incision under the arm to remove all or a portion of the thyroid or parathyroid glands without leaving a scar on the neck.
Researchers at Wake Forest University School of Medicine and the University of Wisconsin-Madison have discovered that some elevated prostate-specific antigen (PSA) levels in men may be caused by a hormone normally occurring in the body, and are not necessarily a predictor of the need for a prostate biopsy.
Embryonic stem cells provide model; goal is to prevent bone loss.
BEDFORD, Mass., Jan. 6 /PRNewswire/ -- MicroCHIPS, Inc., a developer of intelligent implanted devices, has named Massachusetts General Hospital endocrinologist, Robert M. Neer, MD, to its Scientific Advisory Board.
Cytochroma has initiated a Phase II clinical trial of CTA018 injection, the company's product candidate for the treatment of secondary hyperparathyroidism in patients with chronic kidney disease.
- To give a box on the ear to.